Publication:
Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis.

dc.contributor.authorBarbarroja, Nuria
dc.contributor.authorArias-de la Rosa, Ivan
dc.contributor.authorLopez-Medina, Clementina
dc.contributor.authorCamacho-Sanchez, Maria Del Rosario
dc.contributor.authorGomez-Garcia, Ignacio
dc.contributor.authorVelez Garcia-Nieto, Antonio
dc.contributor.authorEscudero-Contreras, Alejandro
dc.contributor.authorLopez-Pedrera, Chary
dc.contributor.authorLopez-Montilla, Maria Dolores
dc.contributor.authorCollantes-Estevez, Eduardo
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderFondo europeo de desarrollo regional de la Union Europea,
dc.contributor.funderJunta de Andalucia
dc.date.accessioned2023-02-08T14:49:23Z
dc.date.available2023-02-08T14:49:23Z
dc.date.issued2019-10-16
dc.description.abstractCardiovascular disease (CVD) is the main cause of mortality in patients with psoriatic disease. Traditional cardiovascular (CV) risk factors, such as arterial hypertension (HTA), type 2 diabetes (T2D), and dyslipidaemia are more prevalent in these patients compared with the general population.1 Besides, the chronic inflammatory state induced by psoriatic disease contributes to subclinical atherosclerosis, making it possible to consider psoriatic disease as an independent CV risk factor.2 In fact, accelerated atherosclerosis has been associated with both psoriasis and psoriatic arthritis (PsA), progression of which is responsible for the majority of CVD mortality in these patients
dc.identifier.citationBarbarroja N, Arias-de la Rosa I, López-Medina C, Camacho-Sánchez MDR, Gómez-García I, Vélez-García AJ, et al. Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. Ther Adv Musculoskelet Dis. 2019 Oct 16;11:1759720X19880742
dc.identifier.doi10.1177/1759720X19880742
dc.identifier.issn1759-720X
dc.identifier.pmcPMC6796210
dc.identifier.pmid31662800
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796210/pdf
dc.identifier.unpaywallURLhttps://journals.sagepub.com/doi/pdf/10.1177/1759720X19880742
dc.identifier.urihttp://hdl.handle.net/10668/15522
dc.journal.titleTherapeutic advances in musculoskeletal disease
dc.journal.titleabbreviationTher Adv Musculoskelet Dis
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number3
dc.publisherSage Publications
dc.pubmedtypeJournal Article
dc.relation.projectIDPI17/01316
dc.relation.publisherversionhttps://journals.sagepub.com/doi/abs/10.1177/1759720X19880742?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectArthritis, psoriatic
dc.subjectCardiovascular diseases
dc.subjectDiabetes mellitus, type 2
dc.subjectTechnology assessment, biomedical
dc.subject.decsAterosclerosis
dc.subject.decsDislipidemias
dc.subject.decsFactores de fiesgo
dc.subject.decsHipertensión
dc.subject.decsInflamación
dc.subject.meshPsoriasis
dc.subject.meshRisk factors
dc.subject.meshHypertension
dc.subject.meshInflammation
dc.subject.meshAtherosclerosis
dc.subject.meshDyslipidemias
dc.titleCardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6796210.pdf
Size:
469.53 KB
Format:
Adobe Portable Document Format